This Insight Pharma Report:
This research begins by considering definitions for backup compounds, reviewing key literature references that present expert views on the topic, and presenting case studies that describe how medicinal chemists approach design and selection of backup compounds. Backup strategies currently in effect, and the types of issues companies consider when deciding whether to designate and advance backup compounds once a drug candidate is selected, are examined. These issues include the necessity for backup compounds; whether backup strategies are ad hoc or policy-based; whether to advance backups based on the same or different chemical scaffold as the prototype; how to best deal with addressing backup compound-related questions before a prototype has advanced to the stage where information needed for such decision-making becomes available; and the role of biomarkers and backup compounds in drug repositioning.
Get your copy of this report @ http://www.reportsnreports.com/reports/157192-backup-compound-strategies-commercial-and-tactical-considerations-overview.html
Released On: 9/3/2012
Views: 3124
Released On: 8/31/2012
Views: 3858
Released On: 8/27/2012
Views: 2139
Released On: 8/23/2012
Views: 2993
Released On: 8/23/2012
Views: 2018
Released On: 8/21/2012
Views: 2711
Released On: 8/16/2012
Views: 3351
Released On: 8/16/2012
Views: 1968
Released On: 8/16/2012
Views: 4217
Released On: 8/14/2012
Views: 2093
Released On: 8/14/2012
Views: 1797